Evidence map›Paper›PMID 24248812›Full record

ArticleGenetic epidemiology2014

Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions.

Anja Schoeps, Anja Rudolph, Petra Seibold, Alison M Dunning, Roger L Milne, Stig E Bojesen, Anthony Swerdlow, Irene Andrulis, Hermann Brenner, Sabine Behrens and 71 more

Open access · hybridAbstract read
In one paragraph

Article in Genetic epidemiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Field cancerization in breast cancer.The Journal of pathology · 2022
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Common Genetic Variation and Breast Cancer Risk-Past, Present, and Future.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2018
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Discriminatory power of common genetic variants in personalized breast cancer diagnosis.Proceedings of SPIE--the International Society for Optical Engineering · 2016
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

81 authors at 20 institutions in 16 countries.

Anja SchoepsDepartment of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Institute of Public Health, University of Heidelberg, Heidelberg, Germany.
Anja Rudolph
Petra Seibold
Alison M Dunning
Roger L Milne
Stig E Bojesen
Anthony Swerdlow
Irene Andrulis
Hermann Brenner
Sabine Behrens
Nicholas Orr
Michael Jones
Alan Ashworth
Jingmei Li
Helen Cramp
Dan Connley
Kamila Czene
Hatef Darabi
Stephen J Chanock
Jolanta Lissowska
Jonine D Figueroa
Julia Knight
Gord Glendon
Anna M Mulligan
Martine Dumont
Gianluca Severi
Laura Baglietto
Janet Olson
Celine Vachon
Kristen Purrington
Matthieu Moisse
Patrick Neven
Hans Wildiers
Amanda Spurdle
Veli-Matti Kosma
Vesa Kataja
Jaana M Hartikainen
Ute Hamann
Yon-Dschun Ko
Aida K Dieffenbach
Volker Arndt
Christa Stegmaier
Núria Malats
José I Arias Perez
Javier Benítez
Henrik Flyger
Børge G Nordestgaard
Thérèse Truong
Emilie Cordina-Duverger
Florence Menegaux
Isabel dos Santos Silva
Olivia Fletcher
Nichola Johnson
Lothar Häberle
Matthias W Beckmann
Arif B Ekici
Linde Braaf
Femke Atsma
Alexandra J van den Broek
Enes Makalic
Daniel F Schmidt
Melissa C Southey
Angela Cox
Jacques Simard
Graham G Giles
Diether Lambrechts
Arto Mannermaa
Hiltrud Brauch
Pascal Guénel
Julian Peto
Peter A Fasching
John Hopper
Dieter Flesch-Janys
Fergus Couch
Georgia Chenevix-Trench
Paul D P Pharoah
Montserrat Garcia-Closas
Marjanka K Schmidt
Per Hall
Douglas F Easton
Jenny Chang-Claude
German Cancer Research Center · DEThe University of Melbourne · AUInstitute of Cancer Research · GBHerlev Hospital · DKUniversité Paris-Sud · FRDutch Cancer Society · NLFriedrich-Alexander-Universität Erlangen-Nürnberg · DEKarolinska Institutet · SEMayo Clinic Health System · USSpanish National Cancer Research Centre · ESUniversity of Cambridge · GBUniversity of Eastern Finland · FIUniversity of Sheffield · GBCentre hospitalier universitaire de Québec · CAGenome Institute of Singapore · SGLondon School of Hygiene & Tropical Medicine · GBMount Sinai Hospital · CANational Cancer Institute · USQIMR Berghofer Medical Research Institute · AUUniversitair Ziekenhuis Leuven · BE

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI AKHILESH PANDEY · 1985 to 2026
$151.3M
Hormone-Related CancersZIACP010126 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI GIERACH, GRETCHEN · 2009 to 2025
$103.5M
The Role of CHFR in Tumorigenesis and Paclitaxel-Sensitivity in Breast CancerP50CA116201 · NCI · MAYO CLINIC ROCHESTER · PI Fergus Joseph Couch · 2005 to 2026
$49.9M
Northern California Cooperative Family Registry for Breast CancerU01CA069417 · NCI · NORTHERN CALIFORNIA CANCER CENTER · PI JOHN, ESTHER M. · 1995 to 2010
$22.4M
Core-001U01CA164920 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Irene Andrulis, Sarah Violet Colonna · 2018 to 2026
$17.0M
Breast Cancer Family Registry CohortUM1CA164920 · NCI · CANCER PREVENTION INSTIT OF CALIFORNIA · PI ANDRULIS, IRENE, BUYS, SAUNDRA S · 2012 to 2017
$12.7M
Epidemiologic StudiesU19CA148065 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI AHSAN, HABIBUL, BRUGGE, JOAN SIEFERT · 2010 to 2014
$10.6M
Epidemiological and Clinical Translational Studies Post Genome-Wide AssociationU19CA148537 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI EASTON, DOUGLAS FREDERICK, EELES, ROSALIND · 2010 to 2014
$10.4M
ONTARIO REGISTRY FOR STUDIES OF FAMILIAL BREAST CANCERU01CA069467 · NCI · CANCER CARE ONTARIO · PI ANDRULIS, IRENE L. · 1995 to 2010
$10.4M
Ovarian cancer GWAS discovery, expansion and replication (N2 - Project #1)U19CA148112 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI SELLERS, THOMAS A · 2010 to 2014
$10.2M
THE AUSTRALIAN BREAST CANCER FAMILY REGISTRYU01CA069638 · NCI · UNIVERSITY OF MELBOURNE · PI HOPPER, JOHN L · 1995 to 2010
$6.6M
A genome-wide association study for breast cancer in BRCA1 mutation carriersR01CA128978 · NCI · MAYO CLINIC ROCHESTER · PI COUCH, FERGUS JOSEPH · 2008 to 2012
$4.8M
Breast Cancer Now BREAST CANCER NOW RESEARCH CENTRECancer Research UK 10118Cancer Research UK 10124Cancer Research UK 11022Cancer Research UK 16561Cancer Research UK 16563Cancer Research UK 16565Cancer Research UK C12292/A11174Cancer Research UK C1281/A12014Cancer Research UK C1287/A10118Cancer Research UK C1287/A 10710Cancer Research UK C1287/A12014Cancer Research UK C490/A10119Cancer Research UK C490/A10124Cancer Research UK C5047/A10692Cancer Research UK C5047/A15007Cancer Research UK C5047/A8384Cancer Research UK C8197/A10123CIHRIntramural NIH HHSNCI NIH HHS 1U19 CA148065NCI NIH HHS 1U19 CA148112NCI NIH HHS 1U19 CA148537NCI NIH HHS CA128978NCI NIH HHS P30 CA015083NCI NIH HHS P50 CA116201NCI NIH HHS R01 CA128978NCI NIH HHS RFA-CA-06-503NCI NIH HHS U01 CA069417NCI NIH HHS U01 CA069467NCI NIH HHS U01 CA069638NCI NIH HHS U01 CA164920NCI NIH HHS U01 CA69417NCI NIH HHS U01 CA69467NCI NIH HHS U01 CA69638NCI NIH HHS U19 CA148065NCI NIH HHS U19 CA148112NCI NIH HHS U19 CA148537NCI NIH HHS UM1 CA164920
6 · The paper itself

Abstract

Genes that alter disease risk only in combination with certain environmental exposures may not be detected in genetic association analysis. By using methods accounting for gene-environment (G × E) interaction, we aimed to identify novel genetic loci associated with breast cancer risk. Up to 34,475 cases and 34,786 controls of European ancestry from up to 23 studies in the Breast Cancer Association Consortium were included. Overall, 71,527 single nucleotide polymorphisms (SNPs), enriched for association with breast cancer, were tested for interaction with 10 environmental risk factors using three recently proposed hybrid methods and a joint test of association and interaction. Analyses were adjusted for age, study, population stratification, and confounding factors as applicable. Three SNPs in two independent loci showed statistically significant association: SNPs rs10483028 and rs2242714 in perfect linkage disequilibrium on chromosome 21 and rs12197388 in ARID1B on chromosome 6. While rs12197388 was identified using the joint test with parity and with age at menarche (P-values = 3 × 10(-07)), the variants on chromosome 21 q22.12, which showed interaction with adult body mass index (BMI) in 8,891 postmenopausal women, were identified by all methods applied. SNP rs10483028 was associated with breast cancer in women with a BMI below 25 kg/m(2) (OR = 1.26, 95% CI 1.15-1.38) but not in women with a BMI of 30 kg/m(2) or higher (OR = 0.89, 95% CI 0.72-1.11, P for interaction = 3.2 × 10(-05)). Our findings confirm comparable power of the recent methods for detecting G × E interaction and the utility of using G × E interaction analyses to identify new susceptibility loci.

Indexed as

Gene-Environment InteractionAdolescentBody HeightBody Mass IndexBreast NeoplasmsChromosomes, Human, Pair 21Chromosomes, Human, Pair 6FemaleGenetic LociGenetic Predisposition to DiseaseHumansLinkage DisequilibriumMenarcheMiddle AgedParityPolymorphism, Single Nucleotidebody mass indexbreast cancer riskcase-control studygene-environment interactionpolymorphisms

Identifiers

PMID24248812
PMCPMC3995140
OpenAlexW2082458892

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.